Vimarsana
Biggest News Aggregation in the World

Pharm Gmb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharm Gmb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharm Gmb Today - Breaking & Trending Today

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy - Vimarsana News

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy

EQS-News: Dermapharm Holding SE / Key word: Quarterly / Interim Statement/Quarter Results Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's...

Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma - Vimarsana News

Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma

A U.S. appeals court overruled its prior decision, deciding that the patent for Novartis AG’s blockbuster drug Gilenya ...

Dermapharm successfully acquires C³ Group - Vimarsana News

Dermapharm successfully acquires C³ Group

31.01.2022 Dermapharm successfully acquires C³ Group | Dermapharm Holding SE | News | Nachricht | Mitteilung

Source: dgap.de
Dermapharm successfully acquires C³ Group - Vimarsana News

Dermapharm successfully acquires C³ Group

DGAP-News: Dermapharm Holding SE / Key word(s): Mergers & Acquisitions/Expansion31.01.2022 / 10:02 The issuer is solely responsible for the content of this announcement.Dermapharm successfully acquires C³ Group Grünwald, 31 January 2022 - Dermapharm Holding SE ("Dermapharm"), a fast-growing manufacturer of branded p...

DGAP-News: Dermapharm successfully acquires C³ Group Seite 1 - Vimarsana News

DGAP-News: Dermapharm successfully acquires C³ Group Seite 1

31.01.2022 - DGAP-News: Dermapharm Holding SE / Key word(s): Mergers & Acquisitions/Expansion Dermapharm successfully acquires C³ Group 31.01.2022 / 10:02 The issuer is solely responsible for the content of this announcement. Dermapharm successfully acquires ... Seite 1